Stay up to date with our latest news and events.
Proteos is a leader in customized recombinant antibody production offering production of full-length IgG, F(ab) and (Fab’)2 antibody fragments, and antibody fusion proteins. It is often beneficial for researchers to produce multiple antibodies simultaneously for functional screening studies. This type of production can be prohibitive at large scales due to cost constraints and at very small scales due to low production yields. Proteos provides researchers a solution with our medium-throughput antibody production service.
Proteos, Inc. and Protea Biosciences Group, Inc. announced today that they have entered into a joint co-marketing agreement. This mutual partnership allows Protea to combine Proteos' protein production capabilities alongside Protea's proprietary bioanalytical services, and allows Proteos to market and promote Protea's proprietary bioanalytical services with their custom protein production services
Proteos will be exhibiting at the Protein Engineering Summit (PEGS Boston). Please stop by booth #321 to learn why Proteos is an industry leader in the production of high-quality recombinant proteins and antibodies.
High-quality labeled antibodies are crucial for many research applications including Western blotting, ELISA, immunofluorescence, immunohistochemistry, and flow cytometry. Specialized conjugates are not always commercially available but can be custom produced to your specifications at Proteos.
An accurate baculovirus titer is essential for optimal insect cell expression and reproducibility. Proteos offers a rapid, economical flow cytometry assay for titer determination.
The Michael J. Fox Foundation's Strategy to Generate, Characterize, and Distribute Preclinical Alpha-Synuclein Research Tools for Molecular Biology presented at Neuroscience 2016.
The Michael J. Fox Foundation will be presenting a poster at this year’s conference describing the research tools program: The Michael J. Fox Foundation's Strategy to Generate, Characterize, and Distribute Preclinical Alpha-Synuclein Research Tools for Molecular Biology
Proteos will be exhibiting at Neuroscience 2016. Please stop by booth 4304 to meet us and learn why we are an industry leader in the production of recombinant proteins and antibodies.
Celebrating over 30,000 attendees from over 80 countries, the Society for Neuroscience's (SfN) annual meeting is the world's premier destination for anyone seeking ideas and tools related to the field. With members able to view more than 15,000 abstracts, explore countless exhibits and network with other professionals in the field, the meeting aims to assist neuroscience professionals at all stages of their careers.
The Michael J. Fox Foundation (MJFF) first goal is to propel breakthroughs that Parkinson's sufferers can immediately feel in their day to day lives. The foundation realizes the importance of protein reagents in many applications related to treating Parkinson's disease. MJFF has partnered with Proteos who provides them with the best quality reagents to support research of Parkinson's disease.
